[1]
G. Gellerman, “THERANOSTIC ANTIBODY-DRUG CONJUGATES: NEW FRONTIERS IN DIAGNOSIS AND TREATMENT OF CANCER”, ccw, vol. 1, no. 1, p. 14, Oct. 2022.